Penumbra Company Profile (NYSE:PEN)

About Penumbra (NYSE:PEN)

Penumbra logoPenumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment
  • Sub-Industry: N/A
  • Symbol: NYSE:PEN
  • CUSIP: N/A
  • Web:
  • Market Cap: $2.75741 billion
  • Outstanding Shares: 33,627,000
Average Prices:
  • 50 Day Moving Avg: $86.33
  • 200 Day Moving Avg: $80.95
  • 52 Week Range: $56.05 - $91.00
  • Trailing P/E Ratio: 293.91
  • Foreward P/E Ratio: 820.00
  • P/E Growth: -32.56
Sales & Book Value:
  • Annual Revenue: $278.61 million
  • Price / Sales: 9.90
  • Book Value: $11.11 per share
  • Price / Book: 7.38
  • EBIDTA: ($2,820,000.00)
  • Net Margins: -2.31%
  • Return on Equity: -2.25%
  • Return on Assets: -1.96%
  • Current Ratio: 9.66%
  • Quick Ratio: 7.60%
  • Average Volume: 177,100 shs.
  • Beta: 0.15
  • Short Ratio: 17.55
Frequently Asked Questions for Penumbra (NYSE:PEN)

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra, Inc. (NYSE:PEN) posted its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.04. The company earned $73.21 million during the quarter, compared to analyst estimates of $71.08 million. Penumbra had a negative return on equity of 2.25% and a negative net margin of 2.31%. The business's revenue for the quarter was up 26.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.07 earnings per share. View Penumbra's Earnings History.

Where is Penumbra's stock going? Where will Penumbra's stock price be in 2017?

2 equities research analysts have issued 1 year price targets for Penumbra's shares. Their forecasts range from $94.00 to $96.00. On average, they expect Penumbra's share price to reach $95.00 in the next twelve months. View Analyst Ratings for Penumbra.

Who are some of Penumbra's key competitors?

Who are Penumbra's key executives?

Penumbra's management team includes the folowing people:

  • Adam Elsesser, Chairman of the Board, President, Chief Executive Officer
  • Sridhar Kosaraju, Chief Financial Officer and Head of Strategy
  • Daniel Donen Davis, President, North America
  • James Pray, President, International
  • Robert D. Evans, Executive Vice President, General Counsel, Secretary
  • Lynn Rothman, Executive Vice President and Chief Business Officer
  • Arani Bose M.D., Executive Director and Chief Innovator
  • Harpreet S. Grewal, Independent Director
  • Don W. Kassing, Presiding Independent Director
  • Bridget O'Rourke, Independent Director

How do I buy Penumbra stock?

Shares of Penumbra can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Penumbra's stock price today?

One share of Penumbra stock can currently be purchased for approximately $82.00.

MarketBeat Community Rating for Penumbra (NYSE PEN)
Community Ranking:  3.6 out of 5 (  )
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  119
MarketBeat's community ratings are surveys of what our community members think about Penumbra and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Penumbra (NYSE:PEN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $95.00 (15.85% upside)

Analysts' Ratings History for Penumbra (NYSE:PEN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/16/2017BMO Capital MarketsReiterated RatingBuy$96.00LowView Rating Details
6/13/2017Canaccord GenuityReiterated RatingBuy$94.00HighView Rating Details
3/14/2016Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
10/13/2015Bank of America CorporationInitiated CoverageBuy -> Buy$46.00 -> $46.00N/AView Rating Details
10/13/2015J P Morgan Chase & CoInitiated CoverageOverweight$46.00N/AView Rating Details
(Data available from 7/23/2015 forward)


Earnings History for Penumbra (NYSE:PEN)
Earnings by Quarter for Penumbra (NYSE:PEN)
Earnings History by Quarter for Penumbra (NYSE PEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.06)($0.10)$71.08 million$73.21 millionViewListenView Earnings Details
2/28/2017Q416($0.09)($0.08)$67.54 million$73.10 millionViewListenView Earnings Details
11/3/2016Q316($0.08)($0.04)$63.25 million$67.20 millionViewN/AView Earnings Details
8/9/2016Q216($0.07)$0.01$58.18 million$65.10 millionViewN/AView Earnings Details
5/9/2016Q116($0.07)$0.02$53.10 million$57.90 millionViewN/AView Earnings Details
3/8/2016Q415($0.10)$0.05$46.76 million$54.40 millionViewN/AView Earnings Details
11/12/2015Q315($0.15)$0.03$43.00 million$50.42 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Penumbra (NYSE:PEN)
Current Year EPS Consensus Estimate: $-0.16 EPS
Next Year EPS Consensus Estimate: $0.1 EPS


Dividend History for Penumbra (NYSE:PEN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Penumbra (NYSE:PEN)
Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 68.67%
Insider Trades by Quarter for Penumbra (NYSE:PEN)
Institutional Ownership by Quarter for Penumbra (NYSE:PEN)
Insider Trades by Quarter for Penumbra (NYSE:PEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/18/2017Thomas WilderDirectorSell345$86.10$29,704.50View SEC Filing  
4/24/2017Robert D EvansEVPSell10,000$85.24$852,400.00View SEC Filing  
2/14/2017Robert D EvansEVPSell5,000$75.00$375,000.00View SEC Filing  
2/13/2017Adam ElsesserCEOSell7,700$72.21$556,017.00View SEC Filing  
2/13/2017James Robert PrayInsiderSell1,700$73.04$124,168.00View SEC Filing  
2/13/2017Sridhar KosarajuCFOSell1,600$72.94$116,704.00View SEC Filing  
2/10/2017James Robert PrayInsiderSell23,900$71.08$1,698,812.00View SEC Filing  
2/10/2017Sridhar KosarajuCFOSell15,500$71.49$1,108,095.00View SEC Filing  
2/9/2017Arani BoseInsiderSell22,300$70.44$1,570,812.00View SEC Filing  
2/9/2017Lynn RothmanEVPSell2,700$70.20$189,540.00View SEC Filing  
2/7/2017James Robert PrayInsiderSell4,099$69.09$283,199.91View SEC Filing  
2/7/2017Robert D EvansEVPSell1$70.00$70.00View SEC Filing  
2/6/2017Arani BoseInsiderSell17,100$70.01$1,197,171.00View SEC Filing  
2/6/2017Lynn RothmanEVPSell2,886$70.41$203,203.26View SEC Filing  
2/6/2017Sridhar KosarajuCFOSell100$70.00$7,000.00View SEC Filing  
2/3/2017James Robert PrayInsiderSell15,600$70.39$1,098,084.00View SEC Filing  
2/3/2017Robert D EvansEVPSell5,000$70.35$351,750.00View SEC Filing  
2/3/2017Sridhar KosarajuCFOSell7,800$70.56$550,368.00View SEC Filing  
2/1/2017Adam ElsesserCEOSell21,400$70.98$1,518,972.00View SEC Filing  
2/1/2017Daniel Donen DavisInsiderSell7,298$71.00$518,158.00View SEC Filing  
2/1/2017Lynn RothmanEVPSell4,414$70.99$313,349.86View SEC Filing  
1/31/2017Adam ElsesserCEOSell9,000$71.26$641,340.00View SEC Filing  
1/31/2017Daniel Donen DavisInsiderSell3,000$71.29$213,870.00View SEC Filing  
1/31/2017Lynn RothmanEVPSell1,800$71.27$128,286.00View SEC Filing  
1/30/2017Adam ElsesserCEOSell8,200$70.72$579,904.00View SEC Filing  
1/30/2017Daniel Donen DavisInsiderSell2,698$70.71$190,775.58View SEC Filing  
1/30/2017Lynn RothmanEVPSell1,700$70.79$120,343.00View SEC Filing  
1/27/2017Arani BoseInsiderSell31,500$74.12$2,334,780.00View SEC Filing  
1/27/2017Lynn RothmanEVPSell7,000$74.24$519,680.00View SEC Filing  
1/26/2017Don W KassingDirectorSell3,000$74.50$223,500.00View SEC Filing  
11/16/2016Sridhar KosarajuCFOSell25,000$65.07$1,626,750.00View SEC Filing  
9/9/2016Adam ElsesserCEOSell57,200$71.07$4,065,204.00View SEC Filing  
9/6/2016Arani BoseInsiderSell61,000$70.72$4,313,920.00View SEC Filing  
9/2/2016Robert D EvansEVPSell3,100$70.10$217,310.00View SEC Filing  
8/31/2016Adam ElsesserCEOSell26,000$71.15$1,849,900.00View SEC Filing  
8/31/2016Robert D EvansEVPSell5,300$71.17$377,201.00View SEC Filing  
8/26/2016Adam ElsesserCEOSell26,800$71.06$1,904,408.00View SEC Filing  
8/26/2016Robert D EvansEVPSell5,300$71.03$376,459.00View SEC Filing  
8/24/2016Adam ElsesserCEOSell29,000$72.95$2,115,550.00View SEC Filing  
8/24/2016Robert D EvansEVPSell6,300$73.00$459,900.00View SEC Filing  
5/23/2016Robert D EvansEVPSell5,000$50.52$252,600.00View SEC Filing  
5/19/2016Don W KassingDirectorSell3,000$48.63$145,890.00View SEC Filing  
5/19/2016Robert D EvansEVPBuy1,538$25.50$39,219.00View SEC Filing  
5/16/2016James Robert PrayInsiderSell32,500$48.51$1,576,575.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Penumbra (NYSE:PEN)
Latest Headlines for Penumbra (NYSE:PEN)
DateHeadline logoContrasting Entellus Medical (ENTL) and Penumbra (NYSE:PEN) - July 23 at 7:51 AM logoETFs with exposure to Penumbra, Inc. : July 21, 2017 - July 22 at 7:31 AM logoPenumbra, Inc. (PEN) Director Sells $29,704.50 in Stock - July 20 at 10:24 PM logo$77.99 Million in Sales Expected for Penumbra, Inc. (NYSE:PEN) This Quarter - July 15 at 9:44 AM logoPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : July 14, 2017 - July 15 at 7:24 AM logo Penumbra, Inc. (NYSE:PEN) Given $89.00 Consensus Price Target by Brokerages - July 15 at 12:44 AM logo Brokerages Anticipate Penumbra, Inc. (PEN) Will Post Earnings of -$0.05 Per Share - July 13 at 8:13 AM logoETFs with exposure to Penumbra, Inc. : July 10, 2017 - July 11 at 6:33 AM logoCritical Comparison: Tactile Systems Technology (TCMD) & Penumbra (PEN) - July 6 at 7:40 AM logoBrokerages Expect Penumbra, Inc. (PEN) to Post ($0.05) EPS - June 29 at 12:42 AM logoPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : June 28, 2017 - June 28 at 4:19 PM logoPenumbra (PEN) at 52-Week High: What's Driving the Stock? - June 28 at 12:18 AM logoETFs with exposure to Penumbra, Inc. : June 26, 2017 - June 27 at 7:12 AM logoPenumbra, Inc. (PEN) Upgraded at BidaskClub - June 22 at 6:04 PM logo$77.99 Million in Sales Expected for Penumbra, Inc. (PEN) This Quarter - June 21 at 12:10 PM logoPenumbra, Inc. (PEN) Expected to Announce Earnings of -$0.05 Per Share - June 19 at 9:00 AM logoPenumbra, Inc. (PEN) Rating Reiterated by BMO Capital Markets - June 16 at 9:23 PM logoBRIEF-Penumbra's voluntary field removal of its 3D revascularization devices will not impact its revenue guidance - June 14 at 12:20 AM logoZacks: Brokerages Set $89.00 Target Price for Penumbra, Inc. (PEN) - June 13 at 8:33 PM logoCanaccord Genuity Reiterates Buy Rating for Penumbra, Inc. (PEN) - June 13 at 11:34 AM logoPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : June 12, 2017 - June 12 at 6:49 PM logoETFs with exposure to Penumbra, Inc. : June 12, 2017 - June 12 at 6:48 PM logoFinancial Analysis: Penumbra (PEN) versus Masimo (MASI) - June 9 at 10:46 AM logoPenumbra, Inc. :PEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 - June 6 at 7:59 PM logoPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : June 1, 2017 - June 1 at 7:59 PM logo Analysts Set $89.00 Price Target for Penumbra Inc (PEN) - May 26 at 4:50 PM logoPenumbra, Inc. – Value Analysis (NYSE:PEN) : May 19, 2017 - May 19 at 7:46 PM logoPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : May 18, 2017 - May 19 at 11:56 AM logoPost Earnings Coverage as Becton, Dickinson and Co.'s Quarterly Revenue Increased 5.2%; EPS Jumped 12.8% - May 16 at 9:54 AM logoEdited Transcript of PEN earnings conference call or presentation 9-May-17 8:30pm GMT - May 11 at 8:47 AM logoPenumbra Inc (PEN) Downgraded by Zacks Investment Research - May 11 at 8:26 AM logoZacks: Brokerages Set $87.67 Target Price for Penumbra Inc (PEN) - May 10 at 8:44 PM logoPenumbra Inc (PEN) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS - May 10 at 4:16 PM logoPenumbra (PEN) Q1 Loss Wider than Expected, View Intact - May 10 at 11:43 AM logoPenumbra Inc (PEN) Given Buy Rating at BMO Capital Markets - May 10 at 7:36 AM logoPenumbra, Inc. Reports First Quarter 2017 Financial Results - May 9 at 6:45 PM logoPenumbra reports 1Q loss - May 9 at 5:44 PM logoPenumbra (PEN) Receives Daily Media Sentiment Score of 0.16 - May 8 at 11:45 PM logoForm 4 Penumbra Inc For: Apr 28 Filed by: Kosaraju Sridhar - May 3 at 7:52 PM logoPenumbra, Inc. to Present at the Bank of America Merrill Lynch 2017 Health Care Conference - May 3 at 7:52 PM logoPenumbra (PEN) Earning Somewhat Negative Press Coverage, AlphaOne Reports - May 2 at 9:32 PM logo-$0.06 Earnings Per Share Expected for Penumbra Inc (PEN) This Quarter - May 1 at 11:02 AM logoPenumbra (PEN) Receiving Favorable Press Coverage, Report Finds - April 28 at 12:30 AM logoForm 3 Penumbra Inc For: Apr 21 Filed by: O'Rourke Bridget - April 26 at 11:08 PM logoInsider Selling: Penumbra Inc (PEN) EVP Sells 10,000 Shares of Stock - April 26 at 8:22 PM logoPenumbra, Inc. Schedules First Quarter 2017 Earnings Release and Conference ... - April 25 at 6:19 PM logoPenumbra, Inc. Schedules First Quarter 2017 Earnings Release and Conference Call for May 9, 2017 at 4:30 PM Eastern Time - April 25 at 6:19 PM logoPenumbra (PEN) Earning Very Favorable Press Coverage, Analysis Shows - April 24 at 12:56 PM logoBRIEF-Penumbra appoints Bridget O'Rourke to board of directors - April 21 at 6:59 PM logoPenumbra, Inc. Appoints Bridget O'Rourke to its Board of Directors - April 21 at 6:59 PM



Penumbra (PEN) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by Staff